Suchergebnisse - "Fielding, Adele K"

PubPharm (9)

1

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14) : a phase 3, multicentre, randomised controlled trial

enthalten in: The Lancet. Haematology | 2022

von Marks, D. | Kirkwood, A. | Rowntree, C. | +23

2

Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology : an equivalence study

enthalten in: Journal of comparative effectiveness research | 2019

von Goswami, P. | Oliva, E. | Ionova, T. | +13

3

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

enthalten in: The New England journal of medicine | 2017

von Kantarjian, H. | Stein, A. | Gökbuget, N. | +23

CommentIn: Nat Rev Clin Oncol. 2017 May;14 (5):264. - PMID 28322244

4

The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial

enthalten in: Haematologica | 2013

von Marks, D. | Moorman, A. | Chilton, L. | +15

5

IGHtranslocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Moorman, A. | Schwab, C. | Ensor, H. | +10

6

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia : final results of the international trial UKALL XII/ECOG2993

enthalten in: British journal of haematology | 2010

von Patel, B. | Rai, L. | Buck, G. | +10

7

T-cell acute lymphoblastic leukemia in adults : clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)

enthalten in: Blood | 2009

von Marks, D. | Paietta, E. | Moorman, A. | +14

8

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era : results from the International ALL Trial MRC UKALLXII/ECOG2993

enthalten in: Blood | 2009

von Fielding, A. | Rowe, J. | Richards, S. | +15

9

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients : final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

enthalten in: Blood | 2008

von Goldstone, A. | Richards, S. | Lazarus, H. | +16

CommentIn: Blood. 2008 Jun 15;111(12):5755; author reply 5755. - PMID 18544698

1
[1]